WOBURN, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell® technology has received...
Company identifies unique two-part extraction and transdermal delivery processVANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp....
All-cause mortality is 50% more likely during this common diabetes complicationSOMERVILLE, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Podimetrics, a...
First-of-its-kind platform provides a turnkey solution to reduce costs and increase access to testingSAN MATEO, Calif., Jan. 18, 2022 (GLOBE...
New huNOG-EXL EA Model Extends Study Windows SignificantlyRENSSELAER, N.Y., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader...
Brazil Phase 2 Pulmonary Long-Hauler clinical trial of COVI-MSC is now authorized to proceed.The study will compare therapy using mesenchymal...
Strong enrollment within multi-cohort TRIDENT-1 Phase 2 registration enabling study of repotrectinib; completion of targeted 60 patients within EXP-4 ROS1+...
PRAX-562 demonstrated robust preclinical antiseizure activity and exhibited an improved preclinical tolerability profile compared to standard-of-care Praxis expects to initiate...
SAN DIEGO, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life...
BEIJING, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of...
LAS VEGAS, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based...
ROSELAND, N.J., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments,...
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2022) - Plantable Health Inc. (NEO: PLBL) ("Plantable" or the "Company"), a leader...
Bloom launches program for K-12 schools for lab-based testing along with supply and management of rapid testsVancouver, British Columbia and...
Proposed Senate Bill 5660 would legalize the supported adult use of psilocybin by people 21 years of age and older...
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company"),...
Canadian brand leading the emerging functional food category partners with industry-leading extraction and manufacturing partner based in Greeley, ColoradoToronto, Ontario--(Newsfile...
Under Mydecine's recently announced Special Access Support and Supply Program, the company will supply cGMP Psilocybin and MDMA to The...
Results validate company’s methodology and provide insight about the rapid evolution of future variants of concern CAMBRIDGE, Mass.--(BUSINESS WIRE)--nference, an...
Company Helped Pioneer New Remote Therapeutic Monitoring (RTM) CPT Codes WASHINGTON--(BUSINESS WIRE)--Limber Health, Inc., a leader in advanced digital health...